期刊文献+

人巨细胞病毒gB基因真核表达载体的构建与鉴定 被引量:3

Construction and Identification of Eukaryotic Expression Vector of Human Cytomegalovirus gB Gene
下载PDF
导出
摘要 目的 克隆人巨细胞病毒 (HCMV)gB基因并构建真核表达载体。方法 根据Genebank中HCMV核苷酸序列设计引物 ,并在引物的 5′端分别加入BamHⅠ、XhoⅠ限制性内切酶位点 ,特异性扩增gB编码基因片段。TA克隆后经双酶切、PCR、测序等鉴定重组质粒 ,再经双酶切、连接构建含HCMVgB编码基因的真核表达载体 ,转染COS7细胞 ,通过间接免疫荧光法 (IFA)检测该重组真核表达载体在COS7细胞中的表达。结果 重组质粒经BamHⅠ、XhoⅠ双酶切成大小为 5 0kb与 2 7kb的片段 ,表明表达载体pcDNA3 1中插入了HCMVgB基因片段 ,测序结果表明读码框正确。重组表达载体pcDNA3 1 gB转染COS7细胞后 ,经IFA检测胞浆中可见黄绿色荧光。结论成功构建了pcDNA3 1 gB真核表达载体 。 Objective To clone human cytomegalovirus (HCMV) gB gene and construct an eukaryotic expression vector.Methods According to the nucleotide sequence of HCMV in Genbank, design and synthesize a pair of primers with BamH I and Xho I sites at 5′-terminal respectively and amplify HCMV gB DNA fragment by PCR. Insert the amplified gB gene fragment into pGEM-T vector and identify the recombinant plasmid by restriction analysis, PCR and sequencing.Subclone the amplified gB gene fragment into an eukaryotic vector pcDNA3.1 by a series of molecular biological methods including restriction digest and ligation, and transfect the recombinant expression plasmid pcDNA 3.1/gB into COS7 cells. Identify the expressed product by IFA.Results Two gene fragments, at the lengths of 5.0 kb and 2.7 kb,were obtained by the digestion of recombinant plasmid pcDNA 3.1 with BamH I and Xho I respectively.It proved that HCMV gB gene fragment was correctly inserted into expression vector pcDNA3.1.Sequencing showed a correct ORF. IFA proved the gB protein was expressed in COS7 cells.Conclusion An eukaryotic expression vector was successfully constructed, and gB protein was expressed in COS7 cells.
出处 《中国生物制品学杂志》 CAS CSCD 2004年第5期284-286,共3页 Chinese Journal of Biologicals
关键词 人巨细胞病毒 GB基因 真核表达载体 gB糖蛋白 表达 重组质粒 HCMV Eukaryotic expression vector gB glycoprotein
  • 相关文献

参考文献3

  • 1Melnick JL, Adam E, Debakey ME. Cytomegalovirus and atherosclerosis.Bioessays, 1995,17: 899-903.
  • 2Myers JD, Fluomoy N, Thomas ED. Nonbanterial pneumonia after allogenic marrow transplantation. A review of ten year's experience. Rey Infect Dis, 1982,4:1119-1132.
  • 3Jacobson MA,French M.Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy.AIDS, 1998,12: S157-163.

同被引文献21

  • 1萨姆布鲁克J 弗里奇EF 曼尼阿蒂斯T 金冬雁 黎孟枫译.分子克隆实验指南[M] 第2版[M].北京:科学出版社,1992..
  • 2Britt WJ, Mach M. Human cytomegalovirus glycoproteins. Intervirology,1996,39:401-412.
  • 3Gonczol E, Hudecz F, Ianacone J, et al. Immune response to isolated cytomegalovirus envelope proteins. J Virol, 1986,58:661-664.
  • 4Britt WJ, Vugler L. Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116(gB). J Virol, 1988,62: 3309-3318.
  • 5Gyudai Z,Endeesz V, Burian K, et al.CTL responses to HCMV gB IEexon4,gB,pp150 and pp28 in healthy individuals: revaluation of prevalence of IE-specific CTLs. J Infect Dis,2000,18(5): 1537-1546.
  • 6Navarro D, Lennette E, Tugizov S, et al. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B. J Med Virol, 1997,52(4) :451-459.
  • 7Howarth M, Elliott T. The processing of antigens delivered as DNA vaccines. Immunol Rev,2004,199:27-39.
  • 8Schleiss M. Progress in cytomegalovirus vaccine development [J]. Herpes,2005,12(3):66-75.
  • 9Gema G, Lilleri D. Monitoring transplant patients for human cytomegalovirus:diagnostic update[J]. Herpes, 2006,13( 1 ) :4 - 11.
  • 10Varnum SM, Streblow DN, Monroe ME, et al. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome[J]. J Viral,2004,78(20) :10960 - 10966.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部